$KLAC

Higgins Bren D. sold $6.6M of KLAC

Higgins Bren D. (EVP & Chief Financial Officer) sold 31,500 shares of KLA CORP (KLAC) at $209.87 ($6.61M total) on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Higgins Bren D.
Published Aug 13, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KLAC
Neutral
high confidence
Mentioned
$KLAC
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLACNeutralLow
01

Why it matters

The filing provides transparency on insider selling activity but does not include new operational, financial, or regulatory information about KLA.

02

Market read

Traders may note insider selling, but the 10b5-1 designation makes it less likely to be a strong standalone catalyst.

03

What to watch

10b5-1 plans can span multiple trades and dates, so a single Form 4 snapshot may not represent the insider’s current view.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-13 after-hours; transaction dated 2026-08-12

Background

The article is a SEC Form 4 insider transaction disclosure for KLA Corp (KLAC).

Company-level read

Ticker impact

$KLACNeutralHigh confidence
Context

KLA CFO Higgins Bren D. sold 31,500 shares on 2026-08-12 under a 10b5-1 plan, worth about $6.61M.

Expected impact

Low likelihood of a sustained price move from this filing alone; any reaction is likely short-lived.

Evidence & confidence

Form 4 discloses the transaction size and that it was executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal; insider sales at a single large-cap semiconductor equipment name rarely reset sector expectations.

None indicated.

None indicated.

Counterpoint

The sale could reflect liquidity needs or diversification rather than bearish expectations, especially given the stated 10b5-1 plan.

Key entities

  • KLA Corp

    Subject of the Form 4 insider transaction disclosure.

  • Higgins Bren D.

    EVP and Chief Financial Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.

$AMATMed

Bernstein raises WFE growth estimates, boosts price targets

Bernstein raised its wafer fabrication equipment (WFE) spending forecasts, citing confidence the semiconductor upcycle will continue. It lifted 2026 WFE to $148B (+26.3% YoY), 2027 to $204B (+32.6%), and 2028 to $259B (+27%). Price targets were increased for Lam Research, KLA, and Applied Materials, plus preferences for Tokyo Electron, Kokusai, and ASML.

$PLTRMedAI 8/10

Dow and S&P 500 Hit Record Highs as Palantir Soars 20%, Caterpillar Jumps 10% on Earnings Beat; Oil Plunges 5% on US

US stocks extended gains to three sessions, with the Dow and S&P 500 hitting record highs. Palantir (PLTR) rose about 20% after Q2 results: revenue $1.94B (+93% YoY) and adjusted EPS $0.41 vs $0.35; full-year 2026 revenue outlook raised to $8.150B-$8.158B. Caterpillar (CAT) jumped about 10.5% on Q2 beat and $20.54B revenue. Oil fell ~5% on US-Iran deal hopes.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.